These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36597282)

  • 1. Central serous chorioretinopathy: A review.
    Fung AT; Yang Y; Kam AW
    Clin Exp Ophthalmol; 2023 Apr; 51(3):243-270. PubMed ID: 36597282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INSTRUMENTAL DIFFERENCE IN ASSESSING CHOROIDAL HYPERPERMEABILITY AND PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Lee SM; Kwon HJ; Park SW; Lee JE; Byon IS
    Retina; 2019 Jul; 39(7):1361-1369. PubMed ID: 29554076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
    Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y; Li X; Gong Y
    Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Guo J; Tang W; Liu W; Chang Q; Xu G
    Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Son BK; Kim K; Kim ES; Yu SY
    Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):905-912. PubMed ID: 30617579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.
    Rabiolo A; Zucchiatti I; Marchese A; Baldin G; Sacconi R; Montorio D; Cicinelli MV; Querques L; Bandello F; Querques G;
    Eye (Lond); 2018 Jan; 32(1):55-66. PubMed ID: 29265111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic central serous chorioretinopathy.
    Hanumunthadu D; Tan ACS; Singh SR; Sahu NK; Chhablani J
    Indian J Ophthalmol; 2018 Dec; 66(12):1704-1714. PubMed ID: 30451170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal capillary and venous congestion in central serous chorioretinopathy.
    Prünte C; Flammer J
    Am J Ophthalmol; 1996 Jan; 121(1):26-34. PubMed ID: 8554078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.
    Manayath GJ; Shah VS; Saravanan VR; Narendran V
    Retina; 2018 Jun; 38(6):1195-1204. PubMed ID: 28445211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; Keunen JEE; MacLaren RE; Hoyng CB; Downes SM; Fauser S; Boon CJF
    Acta Ophthalmol; 2021 Nov; 99(7):805-811. PubMed ID: 33565230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.
    Ho M; Lai FHP; Ng DSC; Iu LPL; Chen LJ; Mak ACY; Yip Y; Cheung C; Young AL; Brelen M
    Br J Ophthalmol; 2021 Apr; 105(4):555-560. PubMed ID: 32532761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
    Putnam CM; Vang SS
    Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.